47 related articles for article (PubMed ID: 27008827)
1. Biologics in Leprosy: A Systematic Review and Case Report.
Cogen AL; Lebas E; De Barros B; Harnisch JP; Faber WR; Lockwood DN; Walker SL
Am J Trop Med Hyg; 2020 May; 102(5):1131-1136. PubMed ID: 32157993
[TBL] [Abstract][Full Text] [Related]
2. [Biologics and mycobacterial diseases].
Tsuyuguchi K; Matsumoto T
Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
[TBL] [Abstract][Full Text] [Related]
3. Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasis.
Sauer BC; Teng CC; He T; Leng J; Lu CC; Walsh JA; Shah N; Harrison DJ; Tang DH; Cannon GW
J Med Econ; 2016; 19(1):34-43. PubMed ID: 26337538
[TBL] [Abstract][Full Text] [Related]
4. Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study.
Wu N; Lee YC; Shah N; Harrison DJ
Clin Ther; 2014 Aug; 36(8):1231-41, 1241.e1-3. PubMed ID: 25062652
[TBL] [Abstract][Full Text] [Related]
5. [Some case reports which suggest correlation between biologics and leprosy, Mini-symposium on problems on leprosy].
Ishida Y
Nihon Hansenbyo Gakkai Zasshi; 2016 Jan; 84(3):133-7. PubMed ID: 27008827
[TBL] [Abstract][Full Text] [Related]
6. Biologics for the treatment of autoimmune renal diseases.
Holdsworth SR; Gan PY; Kitching AR
Nat Rev Nephrol; 2016 Apr; 12(4):217-31. PubMed ID: 26949177
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of biologic treatments in Familial Mediterranean Fever.
Akgul O; Kilic E; Kilic G; Ozgocmen S
Am J Med Sci; 2013 Aug; 346(2):137-41. PubMed ID: 23276893
[TBL] [Abstract][Full Text] [Related]
8. Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohort.
Piga M; Chessa E; Ibba V; Mura V; Floris A; Cauli A; Mathieu A
Autoimmun Rev; 2014 Aug; 13(8):873-9. PubMed ID: 24840285
[TBL] [Abstract][Full Text] [Related]
9. Use of biologics in SLE: a review of the evidence from a clinical perspective.
Aytan J; Bukhari MA
Rheumatology (Oxford); 2016 May; 55(5):775-9. PubMed ID: 26424838
[TBL] [Abstract][Full Text] [Related]
10. Restarting biologics and management of patients with flares of inflammatory rheumatic disorders or psoriasis during active tuberculosis treatment.
Cantini F; Prignano F; Goletti D
J Rheumatol Suppl; 2014 May; 91():78-82. PubMed ID: 24789004
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
Reich K; Burden AD; Eaton JN; Hawkins NS
Br J Dermatol; 2012 Jan; 166(1):179-88. PubMed ID: 21910698
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]